Amylyx Pharmaceuticals Inc's total assets for Q1 2024 were $417.46M, a decrease of -19.32% from the previous quarter. AMLX total liabilities were $93.02M for the fiscal quarter, a 10.71% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.